Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 15;19(6):3454.
doi: 10.3390/ijerph19063454.

Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19

Affiliations

Landscape of Molecular Crosstalk Perturbation between Lung Cancer and COVID-19

Aditi Kuchi et al. Int J Environ Res Public Health. .

Abstract

Background: Lung cancer patients have the worst outcomes when affected by coronavirus disease 2019 (COVID-19). The molecular mechanisms underlying the association between lung cancer and COVID-19 remain unknown. The objective of this investigation was to determine whether there is crosstalk in molecular perturbation between COVID-19 and lung cancer, and to identify a molecular signature, molecular networks and signaling pathways shared by the two diseases.

Methods: We analyzed publicly available gene expression data from 52 severely affected COVID-19 human lung samples, 594 lung tumor samples and 54 normal disease-free lung samples. We performed network and pathways analysis to identify molecular networks and signaling pathways shared by the two diseases.

Results: The investigation revealed a signature of genes associated with both diseases and signatures of genes uniquely associated with each disease, confirming crosstalk in molecular perturbation between COVID-19 and lung cancer. In addition, the analysis revealed molecular networks and signaling pathways associated with both diseases.

Conclusions: The investigation revealed crosstalk in molecular perturbation between COVID-19 and lung cancer, and molecular networks and signaling pathways associated with the two diseases. Further research on a population impacted by both diseases is recommended to elucidate molecular drivers of the association between the two diseases.

Keywords: COVID-19; SARS-CoV-2; coronavirus; gene expression; lung cancer; networks; signaling pathways.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest regarding the publication of this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Project design and integrated data analysis workflow of gene expression data from COVID-19, lung cancer and normal lung samples. RNA-Seq data sets were downloaded from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA).
Figure 2
Figure 2
Venn diagram showing signatures of genes uniquely associated with COVID-19 ((A), orange) and a signature of genes associated with lung cancer ((B), blue). A signature of 9026 genes associated with both diseases is shown in the intersection.
Figure 3
Figure 3
Patterns of expression profiles for the top 515 upregulated and downregulated genes in lung cancer and in COVID-19, generated using hierarchical clustering on genes associated with both diseases. Genes are represented in rows, and lung cancer and COVID-19 samples in columns. Red color indicates upregulation and blue represents downregulation.
Figure 4
Figure 4
Highly interconnected gene regulatory networks associated with both COVID-19 and lung cancer. The gene names in red font indicate upregulation and blue font downregulation. The solid lines indicate overlapping functions between the genes in the seven merged networks.
Figure 5
Figure 5
Signaling pathways associated with both COVID-19 and lung cancer represented as bars. The orange solid line indicates the threshold above which a signaling pathway was declared significantly associated with both diseases, as determined by the –log(p-values) shown on the x-axis above. The y-axis shows names of signaling pathways associated with both diseases.

Similar articles

Cited by

References

    1. World Health Organization. [(accessed on 10 February 2022)]. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
    1. Centers for Disease Control and Prevention (CDC) [(accessed on 10 February 2022)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/index.html.
    1. Johns Hopkins University of Medicine (JHU) The Johns Hopkins 30-Minute COVID-19 Briefing: Expert Insights on What You Need to Know Now. [(accessed on 10 February 2022)]. Available online: https://coronavirus.jhu.edu/
    1. Liao Z., del Campo E.R., Salem A., Pang Q., Liu H., Guerra J.L.L. Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak. Lung Cancer. 2020;146:230–235. doi: 10.1016/j.lungcan.2020.05.029. - DOI - PMC - PubMed
    1. Flaherty G.T., Hession P., Liew C.H., Lim B.C.W., Leong T.K., Lim V., Sulaiman L.H. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: A critical literature review with clinical recommendations. Trop. Dis. Travel Med. Vaccines. 2020;6:1–13. doi: 10.1186/s40794-020-00118-y. - DOI - PMC - PubMed

Publication types